IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

Two judges have ordered the administration to lift the freeze. But nonprofits and states still can't get money for contracts ...

The hold on funding and upcoming appropriations cycle pose twin challenges for the historic push to green public spaces.

On January 20, 2025, the White House issued an Executive Order titled Unleashing American Energy. Citing the detrimental effect of ...

The president's focus on fossil fuels is a big change from the Biden administration's push for renewable energy.

(Reuters) - The U.S. government will consider opportunities to "bring greater transparency" for the Medicare drug price ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

Uncertainty lingers for many federally-funded climate, energy and environment projects in Massachusetts, as President Trump ...

Pharma industry anger at US legislation that gives Medicare ... seeking to strike down the negotiation elements of the Inflation Reduction Act (IRA) on the grounds that it is unconstitutional ...

A report by the Natural Resources Council of Maine is looking to provide information before President Trump and congressional ...